➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Harvard Business School
Boehringer Ingelheim
McKinsey

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Physiological Effect: Emesis Suppression

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drugs with Physiological Effect: Emesis Suppression

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076570-001 Aug 28, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076546-001 Aug 20, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
King Pharms Llc TIGAN trimethobenzamide hydrochloride CAPSULE;ORAL 017531-006 Dec 13, 2001 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Par Sterile Products TIGAN trimethobenzamide hydrochloride INJECTABLE;INJECTION 017530-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial   Start Trial
Amneal Pharms MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 201451-002 Feb 23, 2011 AA RX No Yes   Start Trial   Start Trial   Start Trial
Aurex MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 087127-001 Approved Prior to Jan 1, 1982 AA RX No No   Start Trial   Start Trial   Start Trial
Aurex MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 087128-001 Approved Prior to Jan 1, 1982 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Merck
Express Scripts
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.